3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hematopoietic and Lymphatic System Neoplasm
3
Neoplasms
2
Malignant Solid Neoplasm
2
Lung Neoplasms
2
Breast Neoplasms
2
Spondylitis, Ankylosing
1
Smoking Cessation
1
Sarcoma
1
Pyloric Stenosis, Hypertrophic
1
Psoriasis
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Obesity
1
Mouth Neoplasms
1
Mental Disorders
1
Melanoma
1
Malignant Female Reproductive System Neoplasm
1
Lupus Erythematosus, Systemic
1
Localized Head and Neck Carcinoma
1
Laryngeal Neoplasms
1
Inflammatory Bowel Diseases
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Depressive Disorder
1
Depression
1
Crohn Disease
1
Colorectal Neoplasms
1
Colitis, Ulcerative
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Magnetic Resonance Spectroscopy
28
enzalutamide
23
Specimen Handling
20
apalutamide
17
Androgen Antagonists
14
Radiosurgery
13
Radiotherapy
12
Prednisone
12
Docetaxel
12
Abiraterone Acetate
12
abiraterone
10
Biopsy
10
Radiation
8
niraparib
6
luprolide acetate gel depot
6
darolutamide
6
Pluvicto
6
Leuprolide
6
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
6
relugolix
5
gallium 68 PSMA-11
5
cabazitaxel
5
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
5
Nivolumab
5
Gonadotropin-Releasing Hormone
5
bicalutamide
4
Triptorelin Pamoate
4
Surveys and Questionnaires
4
Radiotherapy, Intensity-Modulated
4
Glutamate Carboxypeptidase II
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Interviews as Topic
×
30 days
×
Clear all
No trials found.